Cite

HARVARD Citation

    Clerico, M. et al. (n.d.). Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis. Expert opinion on drug safety. 16 (8), pp. 963-972. [Online]. 
  
Back to record